Shockwave Medical (SWAV) Tops Q4 EPS, Revenue; Guides Above Views

Shockwave Medical (NASDAQ: SWAV) reported Q4 EPS of $3.71, which may not compare to the analyst estimate of $1.00. Revenue for the quarter came in at $144 million versus the consensus estimate of $142.66 million.

GUIDANCE:

Shockwave Medical sees FY2023 revenue of $660-680 million, versus the consensus of $658.58 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• Simply Good Foods (SMPL) Tops Q3 EPS by 7c; offers outlook
• Key things to know ahead of SK Hynix’s blockbuster US listing
• Carmila agrees to buy Dijon shopping centre for €45 million